Back to Search
Start Over
Successful Use of Aliskiren in a Case of IgA- Mesangial Glomerulonephritis Unresponsive to Conventional Therapies
- Source :
- Reviews on Recent Clinical Trials. 14:72-76
- Publication Year :
- 2019
- Publisher :
- Bentham Science Publishers Ltd., 2019.
-
Abstract
- Introduction: The early suspension of Altitude trial in recent years has induced most nephrologists and cardiologists to abandon Aliskiren use. Consequently, the potential usefulness of the direct renin inhibition in IgA glomerulonephritis remained an under-investigated therapeutic option. Case Report: We report the case of a 53 years old IgA GMN patient unresponsive to all conventional anti-angiotensin-2 agents, steroids and immunosuppressants, in which the administration of Aliskiren permitted to achieve and maintain a complete proteinuria remission in the absence of any adverse event. Conclusion: Aliskiren might represent a valid and safe therapeutic option in IgA GMN, although further investigations would be needed to confirm this conclusion.
- Subjects :
- Amide
Male
Time Factors
030232 urology & nephrology
Chronic kidney disease (CKD)
030204 cardiovascular system & hematology
Immunosuppressive Agent
chemistry.chemical_compound
0302 clinical medicine
Fumarates
Ramipril
Proteinuria
Fumarate
Biopsy, Needle
Glomerulonephritis
General Medicine
Middle Aged
Immunohistochemistry
Drug Resistance, Multiple
Direct Renin
Treatment Outcome
Retreatment
Drug Therapy, Combination
Glomerulonephritis iga
medicine.symptom
IgA GMN
Immunosuppressive Agents
Human
medicine.medical_specialty
Time Factor
Urology
Drug Administration Schedule
Follow-Up Studie
03 medical and health sciences
Case report
medicine
Humans
Adverse effect
Pharmacology
business.industry
Glomerulonephritis, IGA
Irbesartan
Aliskiren
medicine.disease
Amides
chemistry
Prednisone
business
Conventional therapie
Follow-Up Studies
Subjects
Details
- ISSN :
- 15748871
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Reviews on Recent Clinical Trials
- Accession number :
- edsair.doi.dedup.....37633dec75662f8c788448aaaf6ec5b3